Heart attack recovery: could a 24-Hour hospital stay be just as safe?

NCT ID NCT06744322

Recruiting now Knowledge-focused Sponsor: Medical University Innsbruck Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether people who have a heart attack can be discharged from the hospital after about 24 hours instead of the usual 36 hours or more. Researchers want to see if early discharge is just as safe and does not increase the risk of death, another heart attack, or unplanned heart-related hospital visits. About 2,070 adults with uncomplicated heart attacks will take part.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE MYOCARDIAL INFARCTION (AMI) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute myocardial infarction myocardial infarction Non-ST Elevated Myocardial Infarction ST-elevation myocardial infarction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE MYOCARDIAL INFARCTION (AMI)

Contacts and locations

Locations

Academic Teaching Hospital Feldkirch
RECRUITING

Feldkirch, Vorarlberg, 6800, Austria
Cardinal Schwarzenberg Hospital Schwarzach
NOT_YET_RECRUITING

Schwarzach im Pongau, Schwarzach Im Pongau, 5620, Austria
Hospital Wiener Neustadt
RECRUITING

Wiener Neustadt, Lower Austria, 2700, Austria
Ludwig Maximilian University Munich
NOT_YET_RECRUITING

Munich, Bavaria, 81377, Germany
Medical University of Graz
RECRUITING

Graz, Styria, 8010, Austria
Medical University of Innsbruck
RECRUITING

Innsbruck, Tyrol, 6020, Austria
Paracelsus Medical University Salzburg
RECRUITING

Salzburg, State of Salzburg, 5020, Austria
University Teaching Hospital Wels-Grieskirchen
RECRUITING

Wels, Upper Austria, 4600, Austria

More trials for these conditions

Other studies related to the condition(s) this trial covers.